Amedisys (NASDAQ:AMED) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report released on Monday. The brokerage issued a buy rating on the health services provider’s stock. Several other equities analysts have also recently weighed in on AMED. TD Cowen increased their price target on Amedisys from $84.00 to $101.00 and gave […]
More Stories
EZCORP, Inc. (NASDAQ:EZPW) Sees Large Increase in Short Interest
EZCORP, Inc. (NASDAQ:EZPW – Get Free Report) was the recipient of a significant increase in short interest in September. As...
Short Interest in Gaia, Inc. (NASDAQ:GAIA) Grows By 8.9%
Gaia, Inc. (NASDAQ:GAIA – Get Free Report) saw a large growth in short interest during the month of September. As...
Cronos Price Reaches $0.0775 (CRO)
Cronos (CRO) traded down 1.4% against the U.S. dollar during the one day period ending at 21:00 PM ET on...
TiraVerse (TVRS) Tops One Day Volume of $1.06
TiraVerse (TVRS) traded 0% higher against the dollar during the 24-hour period ending at 21:00 PM Eastern on October 17th....
Dignity Gold Price Tops $4.47 on Top Exchanges (DIGAU)
Dignity Gold (DIGAU) traded 0.5% higher against the dollar during the 1 day period ending at 21:00 PM ET on...
Zilliqa (ZIL) Price Up 5.9% Over Last 7 Days
Zilliqa (ZIL) traded down 1.8% against the dollar during the one day period ending at 21:00 PM ET on October...